2-[4-[(2,4-dioxothiazolidin-5-ylidene)methyl]phenoxy]-N-(4-methyl-1,3-benzothiazol-2-yl)acetamide

ID: ALA4796336

PubChem CID: 162675911

Max Phase: Preclinical

Molecular Formula: C20H15N3O4S2

Molecular Weight: 425.49

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cccc2sc(NC(=O)COc3ccc(/C=C4\SC(=O)NC4=O)cc3)nc12

Standard InChI:  InChI=1S/C20H15N3O4S2/c1-11-3-2-4-14-17(11)22-19(28-14)21-16(24)10-27-13-7-5-12(6-8-13)9-15-18(25)23-20(26)29-15/h2-9H,10H2,1H3,(H,21,22,24)(H,23,25,26)/b15-9-

Standard InChI Key:  ODUMFGAXJVJOJL-DHDCSXOGSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   21.9348  -24.4414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9337  -25.2651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6458  -25.6782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3555  -25.2646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3527  -24.4378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6440  -24.0325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0630  -24.0266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7763  -24.4325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8639  -25.2484    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   25.6680  -25.4194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0781  -24.7060    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.5248  -24.0968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0074  -26.1688    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.6912  -23.2926    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.2215  -25.6772    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.5100  -25.2640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7978  -25.6761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0863  -25.2628    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.7972  -26.4974    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.3775  -25.6696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6340  -25.3390    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2921  -26.4858    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   17.4924  -26.6537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0883  -25.9467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2758  -25.9441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8664  -26.6478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2755  -27.3556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0866  -27.3547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8695  -25.2351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  8  1  0
 10 13  2  0
 12 14  2  0
  2 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 18 20  1  0
 20 21  2  0
 21 24  1  0
 23 22  1  0
 22 20  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 25 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4796336

    ---

Associated Targets(Human)

HOP-62 (47048 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 425.49Molecular Weight (Monoisotopic): 425.0504AlogP: 3.95#Rotatable Bonds: 5
Polar Surface Area: 97.39Molecular Species: ACIDHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 6.19CX Basic pKa: CX LogP: 3.94CX LogD: 2.62
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.60Np Likeness Score: -2.21

References

1. Joshi H,Patil V,Tilekar K,Upadhyay N,Gota V,Ramaa CS.  (2020)  Benzylidene thiazolidinediones: Synthesis, in vitro investigations of antiproliferative mechanisms and in vivo efficacy determination in combination with Imatinib.,  30  (23.0): [PMID:32961322] [10.1016/j.bmcl.2020.127561]

Source